<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A5E72F91-30E2-45E6-8D19-EDC197FF970A"><gtr:id>A5E72F91-30E2-45E6-8D19-EDC197FF970A</gtr:id><gtr:name>Monash University</gtr:name><gtr:address><gtr:line1>Monash University</gtr:line1><gtr:line2>Level 1, Chancellery Building D</gtr:line2><gtr:line3>26 Sports Walk, Wellington Road</gtr:line3><gtr:postCode>3800</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/81B9C778-858C-483B-938B-2B3FA513890E"><gtr:id>81B9C778-858C-483B-938B-2B3FA513890E</gtr:id><gtr:name>Kleijnen Systematic Reviews Ltd, York, UK</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2B4890EC-5704-4F99-AE13-CC1371378CBB"><gtr:id>2B4890EC-5704-4F99-AE13-CC1371378CBB</gtr:id><gtr:name>Copenhagen University Hospital</gtr:name><gtr:address><gtr:line1>Kettegaard Alle 30</gtr:line1><gtr:postCode>DK-2650</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8"><gtr:id>D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8</gtr:id><gtr:name>University of Ottawa</gtr:name><gtr:address><gtr:line1>550 Cumberland</gtr:line1><gtr:line4>Ottawa</gtr:line4><gtr:line5>Ontario K1N 6N5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/281C47FD-D6E8-4C73-9326-13C9B2EE2AB8"><gtr:id>281C47FD-D6E8-4C73-9326-13C9B2EE2AB8</gtr:id><gtr:name>Equator Network</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7C6EF8D4-F9EE-4923-AC03-55AEC6164389"><gtr:id>7C6EF8D4-F9EE-4923-AC03-55AEC6164389</gtr:id><gtr:name>Paris Descartes University</gtr:name><gtr:address><gtr:line1>45 Rue Saints Perse</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7254835D-A811-460C-ACFC-C345775924B4"><gtr:id>7254835D-A811-460C-ACFC-C345775924B4</gtr:id><gtr:name>The Cochrane Collaboration</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Social Medicine</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A5E72F91-30E2-45E6-8D19-EDC197FF970A"><gtr:id>A5E72F91-30E2-45E6-8D19-EDC197FF970A</gtr:id><gtr:name>Monash University</gtr:name><gtr:address><gtr:line1>Monash University</gtr:line1><gtr:line2>Level 1, Chancellery Building D</gtr:line2><gtr:line3>26 Sports Walk, Wellington Road</gtr:line3><gtr:postCode>3800</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/81B9C778-858C-483B-938B-2B3FA513890E"><gtr:id>81B9C778-858C-483B-938B-2B3FA513890E</gtr:id><gtr:name>Kleijnen Systematic Reviews Ltd, York, UK</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2B4890EC-5704-4F99-AE13-CC1371378CBB"><gtr:id>2B4890EC-5704-4F99-AE13-CC1371378CBB</gtr:id><gtr:name>Copenhagen University Hospital</gtr:name><gtr:address><gtr:line1>Kettegaard Alle 30</gtr:line1><gtr:postCode>DK-2650</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8"><gtr:id>D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8</gtr:id><gtr:name>University of Ottawa</gtr:name><gtr:address><gtr:line1>550 Cumberland</gtr:line1><gtr:line4>Ottawa</gtr:line4><gtr:line5>Ontario K1N 6N5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/281C47FD-D6E8-4C73-9326-13C9B2EE2AB8"><gtr:id>281C47FD-D6E8-4C73-9326-13C9B2EE2AB8</gtr:id><gtr:name>Equator Network</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7C6EF8D4-F9EE-4923-AC03-55AEC6164389"><gtr:id>7C6EF8D4-F9EE-4923-AC03-55AEC6164389</gtr:id><gtr:name>Paris Descartes University</gtr:name><gtr:address><gtr:line1>45 Rue Saints Perse</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7254835D-A811-460C-ACFC-C345775924B4"><gtr:id>7254835D-A811-460C-ACFC-C345775924B4</gtr:id><gtr:name>The Cochrane Collaboration</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8109D44A-46F3-4581-8103-A0EB362234A9"><gtr:id>8109D44A-46F3-4581-8103-A0EB362234A9</gtr:id><gtr:firstName>Jelena</gtr:firstName><gtr:surname>Savovic</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701659"><gtr:id>2E2DED91-F7A7-4235-A494-7129CDA60655</gtr:id><gtr:title>Empirical investigation of sources of bias in RCTs, using a new Cochrane bias assessment tool</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0701659</gtr:grantReference><gtr:abstractText>Systematic reviews of randomised clinical trials provide the best evidence on the benefits and harms of medical treatments. However, the validity of their results depends on the included trials being conducted with methods that avoid bias. It is therefore standard practice to assess the risk of bias in the results of trials included in a systematic review. Collections of trials included in a large number of systematic reviews can be used to provide empirical evidence of bias in the results of trials.

The Cochrane Collaboration publishes about 300 new systematic reviews each year and aims to set the gold standard for their conduct. The Collaboration is launching a new tool for assessment of the risk of bias in trials. This project will evaluate the practical implementation of this tool. A database of 366 systematic reviews containing 3500 trials will be extended to include data from new Cochrane reviews. We will estimate associations of six types of bias with trial results.

The findings will contribute to improved interpretation of evidence about medical treatments. The results will be used as a basis for recommendations on the conduct and reporting of future trials, and hence ultimately to improved evidence for medicine.</gtr:abstractText><gtr:technicalSummary>Background. Systematic reviews are key in the provision of evidence for clinical decision-making. As the validity of their results depends on that of the included randomised controlled trials (RCTs), it is essential that the methodological quality of the included RCTs is assessed, with bias assessments incorporated into the analysis and interpretation of reviews. The applicant, in her work on the BRANDO study, has combined data from ten empirical studies of the impact of bias on the results of RCTs into a single database containing data from 366 reviews and 3500 RCTs. The Cochrane Collaboration is launching a new tool for the assessment of the risk of bias in RCTs. 

Aims. To evaluate the practical implementation of the Cochrane Collaboration?s new Risk of Bias Tool (ROBT) and to conduct novel empirical research examining the effect of different types of bias on the results of RCTs.

Objectives. 
1. To evaluate the implementation of the ROBT by Cochrane reviewers. 
2. To extend the BRANDO database by incorporating information on new Cochrane reviews including studies evaluated using the ROBT. 
3. To examine associations of high or unclear (compared to low) risk of bias, with intervention effect estimates, for each bias domain included in the ROBT, and in meta-analysis with different characteristics. 
4. To compare the effects of bias observed in studies assessed with the new ROBT with effects of bias observed in previous empirical studies combined in the BRANDO database. 

Design and Methodology. Qualitative research methods will be used to evaluate the practical implementation of the ROBT by Cochrane reviewers. The existing BRANDO database will be expanded to include new Cochrane reviews. A meta-epidemiological approach will be used to examine associations of risk of bias with intervention effect estimates. The effects of bias observed in studies assessed with the new ROBT will be compared with those observed in previous empirical studies combined in thBRANDO database.

Scientific and medical opportunities of the study.
This project will evaluate the impact of flaws in the conduct of recently published trials on intervention effect estimates. Its results will be used to adapt and update the ROBT, and inform guidelines on the conduct and reporting of RCTs. Ultimately, the project will contribute to improved interpretation of evidence about the effect of medical interventions, the improved conduct and reporting of future RCTs, and hence to better medical care.</gtr:technicalSummary><gtr:fund><gtr:end>2012-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>273990</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Cochrane Collaboration</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Cochrane Bias Methods Group</gtr:department><gtr:description>Developing ROBIS - a new tool to assess the risk of bias in systematic reviews</gtr:description><gtr:id>DC488110-9497-41D7-A4A2-9811B7F5312F</gtr:id><gtr:impact>We established collaborations with many international organisations and experts who contributet to the development and piloting of the ROBIS tool, which was published in 2015
Paper: Whiting P, Savovic J, Higgins JP, Caldwell DM, Reeves BC, Shea B, Davies P, Kleijnen J, Churchill R; ROBIS group. ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016 Jan;69:225-34. doi: 10.1016/j.jclinepi.2015.06.005. 
Presentations: We held numerous training workshops of the tool at Cochrane and other meetings
Impact: We have provided training on ROBIS tool to some of the NICE guidelines development teams and to the Estonian Health Insurance Agency, who plan to use the tool for guidelines development. It is also one of the Cochrane-recommended tools for use in overviews.</gtr:impact><gtr:outcomeId>FfzgoYq9Xs8-4</gtr:outcomeId><gtr:partnerContribution>Project design, application for funding, review, participation in the development meeting, refinement. We anticipate that some of the partners will contribute to piloting.</gtr:partnerContribution><gtr:piContribution>We designed the project and successfully applied for funding . I co-led the preliminary review work and produced relevant materials to be considered at the development meeting. I organised the international meeting of experts where we developed the first draft of the risk of bias tool. I am currently co-leading the refinement and making arrangements for piloting</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Cochrane Collaboration</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Extending the Cochrane Collaboration's Risk of Bias tool for non-randomised studies and non-standard trial designs</gtr:description><gtr:id>B302A938-BF04-4920-9029-EAB6B9643BEF</gtr:id><gtr:impact>Successful grant proposal to the Cochrane Collaboration Methods Innovation Fund. The collaboration consisted of research methodologists, epidemiologists, statisticians, editors, and other Cochrane stake-holders.
Publication: Sterne et al. BMJ. 2016 Oct 12;355:i4919. doi: 10.1136/bmj.i4919.

This has led to a further grant from the MRC by Julian Higgins (PI) and collaborators to further develop the tool for different types of study designs.</gtr:impact><gtr:outcomeId>S2Go3SgeSxr-2</gtr:outcomeId><gtr:partnerContribution>Partners contribute in all stages of the development of the tool and piloting.</gtr:partnerContribution><gtr:piContribution>I drfated a grant proposal for this methodological development and applied for funding to the Cochrane Collaboration, together with co-applicants from the Cochrane Bias Methods Group and Non-randomised Studies Methods Group and collaborators from other Cochrane entities.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Data mining approach to assessment of risk of bias in RCTs from published trial reports (PhD project)</gtr:description><gtr:id>AFD5FD33-E565-4EBF-BAD7-1EFEC2AA2387</gtr:id><gtr:impact>Student completed their PhD. They had a paper in which they acknowledged they used data from ROBES study. Project was multidisciplinary, involving the following disciplines: evidence synthesis (including meta-analysis, statistics and epidemiology), and data-mining/ text-mining / programming /computer science.</gtr:impact><gtr:outcomeId>54623ab17d9394.11056637-1</gtr:outcomeId><gtr:partnerContribution>PhD student working on the project.</gtr:partnerContribution><gtr:piContribution>Provided ROBES database and acted as adviser in the study design stages of the PhD project.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Primary Care Health Sciences</gtr:department><gtr:description>Developing Latitudes Network - an online Library of Assessment Tools and InsTruments Used to assess Data validity in Evidence Synthesis</gtr:description><gtr:id>52D0B25F-2909-4F3B-8E19-13C015D6E06D</gtr:id><gtr:impact>Non yet. Collaboration started in October 2013, but we had several unsuccessful attempts to obtain funding. The collaboration is still active but it is difficult to push ahead without dedicated funding. The first manuscript will be submitted for publication this year.</gtr:impact><gtr:outcomeId>UdJFvbgV8VP-2</gtr:outcomeId><gtr:partnerContribution>This at a very early stage now. Partners will provide support for the project and will help us with their Experience with Equator Network.</gtr:partnerContribution><gtr:piContribution>This is a collaboration at an early stage. Our core steering group approached the steering group members of the Equator Network to help us build Latitudes Network online resources in partnership with them. Latitudes Network will be complementary to the Equator Network and provide an accessible online resource for quality and bias assessment tools for health care research. We have planned the initial meeting to plan a bid to fund this initiative.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Cochrane Collaboration</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Developing ROBIS - a new tool to assess the risk of bias in systematic reviews</gtr:description><gtr:id>6DE6872D-6C68-4F44-89D5-09825FCF7443</gtr:id><gtr:impact>We established collaborations with many international organisations and experts who contributet to the development and piloting of the ROBIS tool, which was published in 2015
Paper: Whiting P, Savovic J, Higgins JP, Caldwell DM, Reeves BC, Shea B, Davies P, Kleijnen J, Churchill R; ROBIS group. ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016 Jan;69:225-34. doi: 10.1016/j.jclinepi.2015.06.005. 
Presentations: We held numerous training workshops of the tool at Cochrane and other meetings
Impact: We have provided training on ROBIS tool to some of the NICE guidelines development teams and to the Estonian Health Insurance Agency, who plan to use the tool for guidelines development. It is also one of the Cochrane-recommended tools for use in overviews.</gtr:impact><gtr:outcomeId>FfzgoYq9Xs8-3</gtr:outcomeId><gtr:partnerContribution>Project design, application for funding, review, participation in the development meeting, refinement. We anticipate that some of the partners will contribute to piloting.</gtr:partnerContribution><gtr:piContribution>We designed the project and successfully applied for funding . I co-led the preliminary review work and produced relevant materials to be considered at the development meeting. I organised the international meeting of experts where we developed the first draft of the risk of bias tool. I am currently co-leading the refinement and making arrangements for piloting</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kleijnen Systematic Reviews Ltd, York, UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Developing Latitudes Network - an online Library of Assessment Tools and InsTruments Used to assess Data validity in Evidence Synthesis</gtr:description><gtr:id>E718A63E-9544-4BEE-985A-BCD1882FBA95</gtr:id><gtr:impact>Non yet. Collaboration started in October 2013, but we had several unsuccessful attempts to obtain funding. The collaboration is still active but it is difficult to push ahead without dedicated funding. The first manuscript will be submitted for publication this year.</gtr:impact><gtr:outcomeId>UdJFvbgV8VP-3</gtr:outcomeId><gtr:partnerContribution>This at a very early stage now. Partners will provide support for the project and will help us with their Experience with Equator Network.</gtr:partnerContribution><gtr:piContribution>This is a collaboration at an early stage. Our core steering group approached the steering group members of the Equator Network to help us build Latitudes Network online resources in partnership with them. Latitudes Network will be complementary to the Equator Network and provide an accessible online resource for quality and bias assessment tools for health care research. We have planned the initial meeting to plan a bid to fund this initiative.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Ottawa</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Developing ROBIS - a new tool to assess the risk of bias in systematic reviews</gtr:description><gtr:id>7D46C2ED-C10F-40B8-9915-B393AE520024</gtr:id><gtr:impact>We established collaborations with many international organisations and experts who contributet to the development and piloting of the ROBIS tool, which was published in 2015
Paper: Whiting P, Savovic J, Higgins JP, Caldwell DM, Reeves BC, Shea B, Davies P, Kleijnen J, Churchill R; ROBIS group. ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016 Jan;69:225-34. doi: 10.1016/j.jclinepi.2015.06.005. 
Presentations: We held numerous training workshops of the tool at Cochrane and other meetings
Impact: We have provided training on ROBIS tool to some of the NICE guidelines development teams and to the Estonian Health Insurance Agency, who plan to use the tool for guidelines development. It is also one of the Cochrane-recommended tools for use in overviews.</gtr:impact><gtr:outcomeId>FfzgoYq9Xs8-2</gtr:outcomeId><gtr:partnerContribution>Project design, application for funding, review, participation in the development meeting, refinement. We anticipate that some of the partners will contribute to piloting.</gtr:partnerContribution><gtr:piContribution>We designed the project and successfully applied for funding . I co-led the preliminary review work and produced relevant materials to be considered at the development meeting. I organised the international meeting of experts where we developed the first draft of the risk of bias tool. I am currently co-leading the refinement and making arrangements for piloting</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kleijnen Systematic Reviews Ltd, York, UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Developing ROBIS - a new tool to assess the risk of bias in systematic reviews</gtr:description><gtr:id>A7656138-DF5F-4EBF-9011-A47F4CD5ACEF</gtr:id><gtr:impact>We established collaborations with many international organisations and experts who contributet to the development and piloting of the ROBIS tool, which was published in 2015
Paper: Whiting P, Savovic J, Higgins JP, Caldwell DM, Reeves BC, Shea B, Davies P, Kleijnen J, Churchill R; ROBIS group. ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016 Jan;69:225-34. doi: 10.1016/j.jclinepi.2015.06.005. 
Presentations: We held numerous training workshops of the tool at Cochrane and other meetings
Impact: We have provided training on ROBIS tool to some of the NICE guidelines development teams and to the Estonian Health Insurance Agency, who plan to use the tool for guidelines development. It is also one of the Cochrane-recommended tools for use in overviews.</gtr:impact><gtr:outcomeId>FfzgoYq9Xs8-1</gtr:outcomeId><gtr:partnerContribution>Project design, application for funding, review, participation in the development meeting, refinement. We anticipate that some of the partners will contribute to piloting.</gtr:partnerContribution><gtr:piContribution>We designed the project and successfully applied for funding . I co-led the preliminary review work and produced relevant materials to be considered at the development meeting. I organised the international meeting of experts where we developed the first draft of the risk of bias tool. I am currently co-leading the refinement and making arrangements for piloting</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Clinical Sciences</gtr:department><gtr:description>Developing ROBIS - a new tool to assess the risk of bias in systematic reviews</gtr:description><gtr:id>E3FD137F-9016-42F5-B7AE-8C6359021BAB</gtr:id><gtr:impact>We established collaborations with many international organisations and experts who contributet to the development and piloting of the ROBIS tool, which was published in 2015
Paper: Whiting P, Savovic J, Higgins JP, Caldwell DM, Reeves BC, Shea B, Davies P, Kleijnen J, Churchill R; ROBIS group. ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016 Jan;69:225-34. doi: 10.1016/j.jclinepi.2015.06.005. 
Presentations: We held numerous training workshops of the tool at Cochrane and other meetings
Impact: We have provided training on ROBIS tool to some of the NICE guidelines development teams and to the Estonian Health Insurance Agency, who plan to use the tool for guidelines development. It is also one of the Cochrane-recommended tools for use in overviews.</gtr:impact><gtr:outcomeId>FfzgoYq9Xs8-5</gtr:outcomeId><gtr:partnerContribution>Project design, application for funding, review, participation in the development meeting, refinement. We anticipate that some of the partners will contribute to piloting.</gtr:partnerContribution><gtr:piContribution>We designed the project and successfully applied for funding . I co-led the preliminary review work and produced relevant materials to be considered at the development meeting. I organised the international meeting of experts where we developed the first draft of the risk of bias tool. I am currently co-leading the refinement and making arrangements for piloting</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Biostatistics Unit</gtr:department><gtr:description>COMBAT study: Development of a method for adjusting trial results for biases in meta-analysis: combining generic evidence on bias with detailed trial assessment</gtr:description><gtr:id>F9283495-42EE-4BAA-BF24-05E1F5CE7050</gtr:id><gtr:impact>Funding awarded by MRC in December 2012. Project is expected to complete this year and 2 to 3 manuscripts should be submitted for publication in the next 3-6 months.</gtr:impact><gtr:outcomeId>X9jdnRTudfe-1</gtr:outcomeId><gtr:partnerContribution>The partner (PI) approached us to collaborate to combine their proposed method with ours and wrote the first draft of the grant proposal. They are currently advising on the methods and will have more hands on input at the analysis stage.</gtr:partnerContribution><gtr:piContribution>We contributed to drafting the grant proposal, which was successful. We started assembling data from July 2013.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Biostatistics Unit</gtr:department><gtr:description>How much heterogeneity in meta-analyses is explained by bias in included trials? (PhD project)</gtr:description><gtr:id>5B5926BF-ED15-43C4-AB55-C9831C2A3552</gtr:id><gtr:impact>The project is completed (student completed their PhD successfully) and papers are currently being written. The project is in the field statistics in meta-analysis and meta-epidemiology of bias in trials, so not multidisciplinary.</gtr:impact><gtr:outcomeId>546230c93426d8.33739955-1</gtr:outcomeId><gtr:partnerContribution>The Biostatistics Unit PhD student worked on this new project.</gtr:partnerContribution><gtr:piContribution>I have contributed data from the ROBES study for a PhD project and acted as an external adviser on this methodological PhD project.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Paris - Descartes</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>MetaBlind study</gtr:description><gtr:id>EE694E5A-14B1-45C0-8DC5-DEFE272C07EB</gtr:id><gtr:impact>We submitted a grant proposal to MRC Methodology Panel in June 2013 and this was rejected. Our Danish partners have found funding in Denmark and the majority of this project has been carried out in Denmark. Analyses have been carried out at our institution (by a PhD student) and the manuscripts are currently in preparation. Expected submission in 2017.</gtr:impact><gtr:outcomeId>FMEHJ4CcNm4-2</gtr:outcomeId><gtr:partnerContribution>One of the partners did some pilot work to inform the main research proposal. They contributed a great deal to writing the proposal.</gtr:partnerContribution><gtr:piContribution>We wrote a grant proposal for funding together with the partners.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Copenhagen University Hospital</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:department>Nordic Cochrane Centre</gtr:department><gtr:description>MetaBlind study</gtr:description><gtr:id>879FFD8E-B45B-42DF-B6CA-9A1749BAB85D</gtr:id><gtr:impact>We submitted a grant proposal to MRC Methodology Panel in June 2013 and this was rejected. Our Danish partners have found funding in Denmark and the majority of this project has been carried out in Denmark. Analyses have been carried out at our institution (by a PhD student) and the manuscripts are currently in preparation. Expected submission in 2017.</gtr:impact><gtr:outcomeId>FMEHJ4CcNm4-1</gtr:outcomeId><gtr:partnerContribution>One of the partners did some pilot work to inform the main research proposal. They contributed a great deal to writing the proposal.</gtr:partnerContribution><gtr:piContribution>We wrote a grant proposal for funding together with the partners.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Monash University</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Development of methods for dealing with selective non-reporting of trial results</gtr:description><gtr:id>2F468E5C-81D4-48A0-AE64-48520B3F7587</gtr:id><gtr:impact>No outputs yet.</gtr:impact><gtr:outcomeId>56d99c3c77f276.38948602-1</gtr:outcomeId><gtr:partnerContribution>Visiting senior research associate from Monash University has obtained their own funding to fund their 2-year visit in our institution. The visiting postdoc is currently collaborating with our team on several related projects.</gtr:partnerContribution><gtr:piContribution>We are hosting a visiting senior research associate from Monash University for 2 years. The main topic of their fellowship is Development of methods for dealing with selective non-reporting of trial results. Some of the work on the ROBES study and the data from the ROBES database were used by the fellow for preliminary stages of the collaborative research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Equator Network</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Developing Latitudes Network - an online Library of Assessment Tools and InsTruments Used to assess Data validity in Evidence Synthesis</gtr:description><gtr:id>7C560A14-18EB-4EC9-9BE3-076A5C9A024D</gtr:id><gtr:impact>Non yet. Collaboration started in October 2013, but we had several unsuccessful attempts to obtain funding. The collaboration is still active but it is difficult to push ahead without dedicated funding. The first manuscript will be submitted for publication this year.</gtr:impact><gtr:outcomeId>UdJFvbgV8VP-1</gtr:outcomeId><gtr:partnerContribution>This at a very early stage now. Partners will provide support for the project and will help us with their Experience with Equator Network.</gtr:partnerContribution><gtr:piContribution>This is a collaboration at an early stage. Our core steering group approached the steering group members of the Equator Network to help us build Latitudes Network online resources in partnership with them. Latitudes Network will be complementary to the Equator Network and provide an accessible online resource for quality and bias assessment tools for health care research. We have planned the initial meeting to plan a bid to fund this initiative.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Cochrane Collaboration</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Extending the Cochrane Collaboration's Risk of Bias tool for non-randomised studies and non-standard trial designs</gtr:description><gtr:id>33178719-C5A2-4CC9-AD3B-6966A15AF368</gtr:id><gtr:impact>Successful grant proposal to the Cochrane Collaboration Methods Innovation Fund. The collaboration consisted of research methodologists, epidemiologists, statisticians, editors, and other Cochrane stake-holders.
Publication: Sterne et al. BMJ. 2016 Oct 12;355:i4919. doi: 10.1136/bmj.i4919.

This has led to a further grant from the MRC by Julian Higgins (PI) and collaborators to further develop the tool for different types of study designs.</gtr:impact><gtr:outcomeId>S2Go3SgeSxr-1</gtr:outcomeId><gtr:partnerContribution>Partners contribute in all stages of the development of the tool and piloting.</gtr:partnerContribution><gtr:piContribution>I drfated a grant proposal for this methodological development and applied for funding to the Cochrane Collaboration, together with co-applicants from the Cochrane Bias Methods Group and Non-randomised Studies Methods Group and collaborators from other Cochrane entities.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Cochrane Collaboration</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Cochrane Bias Methods Group</gtr:department><gtr:description>Evaluation of the Cochrane Collaboration's Risk of Bias Tool</gtr:description><gtr:id>E7D5CB8E-8869-4C1C-8EC8-385CC679796F</gtr:id><gtr:impact>1. Funding obtained for the project: &amp;pound;29,354 received by my institution from the Cochrane Opportunities Fund. 

2. Publication in the BMJ, a part of which is based on the results from this collaboration. (see publication section for citation details).

3. Publication currently under review in Systematic Reviews journal (submitted July 2013)

4. This project has led to new collaborations/initiatives:
 - Extending Cochrane Risk of Bias tool for non-randomised studies
 - Revisions of the Cochrane Risk of Bias tool for RCTs</gtr:impact><gtr:outcomeId>D8BA0FD640A-1</gtr:outcomeId><gtr:partnerContribution>All collaborators participated in writing the grant proposal and successfully applying for funding to The Cochrane Collaboration's Opportunities Fund. After the award all collaborators continue to advise on the project.</gtr:partnerContribution><gtr:piContribution>I wrote the first draft of the grant application and then liaised with the collaborators to produce the final version of the application based on all collaborators' input. Lead applicant (PI) for this grant application is my MRC Training Fellowship Sponsor. I worked as a lead researcher on this project (as a part of a 6-month abeyance from my MRC fellowship) from November 2009 to April 2010. The evaluation is now finished, but all of the collaborators are still advising and overseeing the implementation of the recommended changes to the Risk of Bias Tool that came out from the evaluation process.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>69967</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UK Cochrane Centre</gtr:department><gtr:description>the Cochrane Collaboration Methods Innovation Fund</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>The Cochrane Collaboration</gtr:fundingOrg><gtr:id>ED253959-2521-4CAD-9241-D151DF03610E</gtr:id><gtr:outcomeId>oRyDQuMnb5y</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>367999</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Methodology Research Panel</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>M025209</gtr:fundingRef><gtr:id>80C492DA-CD6F-4984-A223-B5831449ED95</gtr:id><gtr:outcomeId>56d98d6b5cce61.90940202</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>283732</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Methodology Panel</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K014587/1</gtr:fundingRef><gtr:id>E6DB7456-0C75-4CC4-8338-CA75E2DF7ED1</gtr:id><gtr:outcomeId>k6vXBAkmJp6</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>29534</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UK Cochrane Centre</gtr:department><gtr:description>The Cochrane Opportunities Fund</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>The Cochrane Collaboration</gtr:fundingOrg><gtr:id>AB9F6B83-665C-4AFF-824E-87016034AA18</gtr:id><gtr:outcomeId>VkbJFfvobv6</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>61954</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Methodology Panel</gtr:description><gtr:end>2014-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K01465X/1</gtr:fundingRef><gtr:id>6C00FA90-D1AC-47C1-AF81-5444377E7B4B</gtr:id><gtr:outcomeId>S3zA65KmSrW</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Hubs for Trial Methodology Research</gtr:department><gtr:description>MRC Hubs for Trial Methodology Research - Network project funding and workshop grants</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L004933/1- N61</gtr:fundingRef><gtr:id>22394493-9449-4D10-B874-2023D78C2836</gtr:id><gtr:outcomeId>56d98aa8d424c0.73077787</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>ROBES database of meta-analyses with risk of bias assessments for meta-epidemiological research.</gtr:description><gtr:id>EF78400E-DEEE-4B63-AAB9-36B222A66C53</gtr:id><gtr:impact>ROBES database is used in the COMBAT study and for 2 PhD projects (one with and external collaborator and one in house).</gtr:impact><gtr:outcomeId>546237af6833b8.20162012</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ROBES database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A1C75DAC-1309-4C8D-8DC5-AC841F89518D</gtr:id><gtr:title>Label-invariant models for the analysis of meta-epidemiological data.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20bbbd109208686dd95da695a9c4f0cd"><gtr:id>20bbbd109208686dd95da695a9c4f0cd</gtr:id><gtr:otherNames>Rhodes KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>5a3bc88160aed5.96698794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CFFB37C-22A3-4CFC-A257-FFF30FE03D5C</gtr:id><gtr:title>Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c31fe7bba76c60899a5429efe9fde2d"><gtr:id>9c31fe7bba76c60899a5429efe9fde2d</gtr:id><gtr:otherNames>Page MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d4be942fe67.06402904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F978ECB-E85F-4C29-9992-7B1B45B727FC</gtr:id><gtr:title>Association Between Risk-of-Bias Assessments and Results of Randomized Trials in Cochrane Reviews: the ROBES Meta-Epidemiologic Study.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/832df148756d511657c37e271ee13c54"><gtr:id>832df148756d511657c37e271ee13c54</gtr:id><gtr:otherNames>Savovic J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>5a981079a44808.01901566</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D9AF596-B691-4551-B667-694436277A5A</gtr:id><gtr:title>Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials.</gtr:title><gtr:parentPublicationTitle>Annals of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/832df148756d511657c37e271ee13c54"><gtr:id>832df148756d511657c37e271ee13c54</gtr:id><gtr:otherNames>Savovic J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-4819</gtr:issn><gtr:outcomeId>pm_14622_22_22945832</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6D2F6FD-149D-483A-AB6F-A079B559D2B6</gtr:id><gtr:title>The rationale for rating risk of bias should be fully reported: response.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1ce860bc84e4e847664fa56855a55b5"><gtr:id>f1ce860bc84e4e847664fa56855a55b5</gtr:id><gtr:otherNames>Whiting P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>585d4be6607090.60375563</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E7207B6-0D86-4009-9245-2DD7D8366EF6</gtr:id><gtr:title>Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews.</gtr:title><gtr:parentPublicationTitle>Systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9835ebb15ad017481aa9b26f20cd705c"><gtr:id>9835ebb15ad017481aa9b26f20cd705c</gtr:id><gtr:otherNames>J?rgensen L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2046-4053</gtr:issn><gtr:outcomeId>585d4be7c5edb3.05240936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E34028D2-A88A-4B7F-8F63-F114E10B0033</gtr:id><gtr:title>Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/832df148756d511657c37e271ee13c54"><gtr:id>832df148756d511657c37e271ee13c54</gtr:id><gtr:otherNames>Savovic J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>pm_14622_22_22989478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C4C0A6E-21FE-4C91-AA47-B99D6A4EA9F8</gtr:id><gtr:title>The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62f63221dc061f0b790a217a27e32074"><gtr:id>62f63221dc061f0b790a217a27e32074</gtr:id><gtr:otherNames>Higgins JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>VxCWi2Q2RTo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66D62760-1C5A-4073-A9AF-D1433D68908E</gtr:id><gtr:title>Development of a combined database for meta-epidemiological research.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/832df148756d511657c37e271ee13c54"><gtr:id>832df148756d511657c37e271ee13c54</gtr:id><gtr:otherNames>Savovic J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>5675e63827ebe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A244FB6-8543-4C0B-A74F-23D7088FCF67</gtr:id><gtr:title>Between-trial heterogeneity in meta-analyses may be partially explained&amp;nbsp;by reported design characteristics.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20bbbd109208686dd95da695a9c4f0cd"><gtr:id>20bbbd109208686dd95da695a9c4f0cd</gtr:id><gtr:otherNames>Rhodes KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>5a70e446d93af2.49229890</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D815ACE-A0D0-4E97-A823-20A5B935E144</gtr:id><gtr:title>A proposed framework for developing quality assessment tools.</gtr:title><gtr:parentPublicationTitle>Systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1ce860bc84e4e847664fa56855a55b5"><gtr:id>f1ce860bc84e4e847664fa56855a55b5</gtr:id><gtr:otherNames>Whiting P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2046-4053</gtr:issn><gtr:outcomeId>5a3bc8264fef03.43842734</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13680838-96E2-408D-8221-5AD59D4A5428</gtr:id><gtr:title>A new large-scale meta-epidemiological study on bias in randomized trials using routinely collected risk-of-bias assessments by cochrane reviewers: results from the robes study</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/832df148756d511657c37e271ee13c54"><gtr:id>832df148756d511657c37e271ee13c54</gtr:id><gtr:otherNames>Savovic J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d99f44d82641.59712228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D2C7C5F-15D7-4C7D-AB64-7C7D8FB71411</gtr:id><gtr:title>Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation.</gtr:title><gtr:parentPublicationTitle>Systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/832df148756d511657c37e271ee13c54"><gtr:id>832df148756d511657c37e271ee13c54</gtr:id><gtr:otherNames>Savovic J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2046-4053</gtr:issn><gtr:outcomeId>54622d7bbe1cb5.15623195</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D68584C2-2B65-4B1C-8924-5E42874B1AA1</gtr:id><gtr:title>Application of causal inference methods in the analyses of randomised controlled trials: a systematic review.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1437662d2ddeda92da753b4b2a41f3c"><gtr:id>d1437662d2ddeda92da753b4b2a41f3c</gtr:id><gtr:otherNames>Farmer RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5a70dea716b885.84826524</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701659</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>208C592B-C1B7-4E87-A19A-04E8D9458E50</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.9  Resources and infrastructure (evaluation of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>